About Us

Wayfinder’s team of seasoned experts in RNA biophysics, molecular biology and machine learning is dedicated to pioneering RNA-targeting small molecule therapies.

Our Scientific Advisory Board is composed of industry leaders in drug discovery and development with a successful history of bringing therapies to the clinic and to the market.

Our Mission: Discovering treatments for currently incurable diseases

Leadership

  • Jason Fontana

    Jason Fontana, PhD

    Founder & CEO

  • David Sparkman-Yager

    David Sparkman-Yager, PhD

    Founder & CTO

  • Chuhern Hwang

    Chuhern Hwang, PhD

    Founder & Head of Drug Discovery

  • Michelle Kriner

    Michelle Kriner, PhD

    Head of Program Development

  • Rao Talasila

    Rao Talasila, MSc

    Head of Machine Learning

Scientific Advisory Board

  • Michael Kauffman, MD PhD

    CEO at Nereid Therapeutics

  • Wayne Gombotz, PhD

    fmr CTO at Alpine Immune Sciences

  • Lance Stewart, PhD

    Interim Executive Director
    at Institute for Protein Design

  • Nick Terrett, PhD

    Medicinal Chemistry Advisor
    fmr Merck, GSK, Pfizer

  • Jay Rothstein, PhD

    CSO at Lifordi Immunotherapeutics

  • Tom McCauley, PhD

    CEO at Neptune Bio

Our Investors